56 Stocks Moving In Friday’s Mid-Day Session
Gainers
Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to $55.
Analyst Ratings for Enfusion
Over the past 3 months, 6 analysts have published their opinion on Enfusion (NYSE:ENFN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Morgan Stanley Maintains Equal-Weight on Enfusion, Lowers Price Target to $8
Morgan Stanley analyst James Faucette maintains Enfusion (NYSE:ENFN) with a Equal-Weight and lowers the price target from $18 to $8.
Enfusion Q1 EPS $(0.10) Misses $0.03 Estimate, Sales $34.10M Beat $33.03M Estimate
Enfusion (NYSE:ENFN) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $0.03 by 433.33 percent. The company reported quarterly sales of $34.10 million which beat the analyst
Goldman Sachs And 3 Other Stocks Insiders Are Selling
Although gold futures traded lower this morning on Friday, there were a few notable insider trades.
Stocks That Hit 52-Week Lows On Friday
During Friday's morning session, 234 stocks hit new 52-week lows.
64 Biggest Movers From Friday
Gainers
Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed FY22 guidance.
Expert Ratings For Enfusion
Enfusion (NYSE:ENFN) has observed the following analyst ratings within the last quarter: